HEALTHCARE & SOCIAL MEDIA
476.1K views | +0 today
Follow

Searching social networks to detect adverse reactions

From advertisinghealth.co.uk

Up to 90% of side effects to drugs are not reported, according to some estimates. “Adverse drug reactions (ADRs) are grossly under reported by everyone, including healthcare professionals, but particularly so by patients,” says David Lewis, head of global safety at Novartis, who is co-ordinating the involvement of pharmaceutical companies in a €2.3m three-year public-private project called Web-RADR (Recognising Adverse Drug Reactions).

Pharma Guy's curator insight, March 17, 2015 8:27 AM


The use of smartphone technology and social media for gathering information on suspected adverse drug reactions (ADRs) is to be evaluated by a new European consortium.


WEB-RADR's founding members include pharma, academics and European medicines regulators like the UK's MHRA and it is funded through the Innovative Medicines Initiative - a partnership between the EC and EFPIA.


The three-year project's goals include developing a mobile app for healthcare professionals and the public to report suspected ADRs to national EU regulators and investigating the potential for publicly available social media data to be used for identifying potential drug safety issues.


WEB-RADR will also make a series of recommendations on how smartphone and social media should be used ethically and scientifically for international drug safety monitoring.

Social Media in Pharma | HealthWorks Collective

From healthworkscollective.com

What are the three letters that spell out a death knell for social media in pharma?
No comment yet.